# Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis

> **NCT00091481** · PHASE4 · COMPLETED · sponsor: **Abbott** · enrollment: 201 (actual)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Zemplar

## Key facts

- **NCT ID:** NCT00091481
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2007-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00091481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00091481, "Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00091481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*